Events Archives - Page 275 of 287

WednesdayDec 07, 2016 11:00 am

Patriot One Technologies (PTOTF) Starts Presentation at LD Micro Main Event

Patriot One Technologies (OTC:PTOTF) is a tech company currently advancing five years of academic research and successful testing into a commercial first-of-its-kind Cognitive Microwave Radar concealed weapons detection system. The company's NForce CMR1000 aims to deter, detect and defend against active shooter threats before they occur. NForce CMR1000 can be cost-effectively installed in hallways and doorways to covertly identify weapons and to alert security of active threats before entry. For more information, visit the company's website at www.patriot1tech.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…

WednesdayDec 07, 2016 11:00 am

NovaBay Pharmaceuticals (NBY) Starts Presentation at LD Micro Main Event

NovaBay Pharmaceuticals (NYSE: NBY) is an innovative biopharmaceutical company that develops and commercializes non-antibiotic anti-infective products for the eye care market. Its commercial products include the Neutrox family of products; Avenova for the eye care market; NovaClear intelli-Case, a device for soft and rigid gas permeable contact lenses; Neutrophase for wound care; CelleRx for the dermatology market; and Aganocide compounds patented synthetic molecules with a range of spectrum of activity against bacteria, viruses and fungi to mimic the mechanism of action against infections with a low likelihood of developing bacterial and viral resistance. For more information, visit the company's website…

WednesdayDec 07, 2016 11:00 am

Asterias Biotherapeutics (AST) Starts Presentation at LD Micro Main Event

Asterias Biotherapeutics (NYSE: AST) is a clinical-stage biotechnology company focusing on developing and commercializing novel therapies in the fields of cell therapy and regenerative medicine specifically for the areas of neurology and oncology. Asterias is developing AST-VAC1, an autologous product candidate that completed phase II clinical trials for the treatment of acute myelogenous leukemia; and AST-VAC2, an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase that is in pre-clinical stage. For more information, visit the company's website at www.asteriasbiotherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and…

WednesdayDec 07, 2016 11:00 am

Biocept (BIOC) Starts Presentation at LD Micro Main Event

Biocept (NASDAQ: BIOC) is a cancer diagnostics company that develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. It offers assays for solid tumor indications, such as breast cancer, lung cancer, gastric cancer, colorectal cancer, prostate cancer and melanoma. For more information, visit the company's website at www.biocept.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…